Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Alpha Teknova

Market Cap: US$226.9m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Immutep

Market Cap: AU$344.9m

A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Aclaris Therapeutics

Market Cap: US$224.2m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

Codexis

Market Cap: US$218.4m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

Quantum-Si

Market Cap: US$216.7m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

Voyager Therapeutics

Market Cap: US$215.2m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

AC Immune

Market Cap: US$212.7m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Korea United Pharm

Market Cap: ₩293.5b

Engages in the manufacture and sale of pharmaceutical products in South Korea.

RAPT Therapeutics

Market Cap: US$210.5m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.

Hyloris Pharmaceuticals

Market Cap: €179.2m

Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.

Instil Bio

Market Cap: US$204.7m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

Heron Therapeutics

Market Cap: US$202.3m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Tenaya Therapeutics

Market Cap: US$202.1m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Genfit

Market Cap: €171.4m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Sirnaomics

Market Cap: HK$1.6b

An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.

BioInvent International

Market Cap: SEK 1.9b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Egetis Therapeutics

Market Cap: SEK 1.9b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

OmniAb

Market Cap: US$196.3m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Forte Biosciences

Market Cap: US$195.4m

Operates as a clinical-stage biopharmaceutical company in the United States.

Invivyd

Market Cap: US$194.5m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

Cellectis

Market Cap: €165.3m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Tarsons Products

Market Cap: ₹17.0b

Manufactures and trades in scientific plastic labware products in India and internationally.

Heidelberg Pharma

Market Cap: €164.0m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.

Innate Pharma

Market Cap: €163.3m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

Xspray Pharma

Market Cap: SEK 1.8b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Eupraxia Pharmaceuticals

Market Cap: CA$264.3m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Enanta Pharmaceuticals

Market Cap: US$190.0m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

C4 Therapeutics

Market Cap: US$190.0m

A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.

Egyptian International Pharmaceutical Industries

Market Cap: ج.م9.1b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

SELLAS Life Sciences Group

Market Cap: US$187.4m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

NervGen Pharma

Market Cap: CA$257.9m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

Journey Medical

Market Cap: US$185.7m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Entrada Therapeutics

Market Cap: US$185.6m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Ventyx Biosciences

Market Cap: US$185.4m

A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.

4basebio

Market Cap: UK£137.0m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

Aardvark Therapeutics

Market Cap: US$184.2m

A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.